drugset / Trial / NCT00992381
Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone
RandomizedCrossoverSingle-blindBasic science
Summary
The purpose of this study is to determine whether the absorption of naproxen from the PN 400 combination (Naprosyn and Esomeprazole) tablets is similar to that from the naproxen tablets (Naprosyn®), which are currently sold in Australia.
Timeline
- Start
- 2009-09
- Primary completion
- —
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 20 mg | — |
| Subject | Naproxen | Small molecule | 500 mg | — |
Indications
No indication recorded.